Literature DB >> 31062355

Molecular dynamics simulations of dihydro-β-erythroidine bound to the human α4β2 nicotinic acetylcholine receptor.

Rilei Yu1,2, Han-Shen Tae3, Qingliang Xu1,2, David J Craik4, David J Adams3, Tao Jiang1,2, Quentin Kaas4.   

Abstract

BACKGROUND AND
PURPOSE: The heteromeric α4β2 nicotinic acetylcholine receptor (nAChR) is abundant in the human brain and is associated with a range of CNS disorders. This nAChR subtype has been recently crystallised in a conformation that was proposed to represent a desensitised state. Here, we investigated the conformational transition mechanism of this nAChR from a desensitised to a closed/resting state. EXPERIMENTAL APPROACH: The competitive antagonist dihydro-β-erythroidine (DHβE) was modelled by replacement of the agonist nicotine in the α4β2 nAChR experimental structure. DHβE is used both in vitro and in vivo for its ability to block α4β2 nAChRs. This system was studied by three molecular dynamics simulations with a combined simulation time of 2.6 μs. Electrophysiological studies of mutated receptors were performed to validate the simulation results. KEY
RESULTS: The relative positions of the extracellular and transmembrane domains in the models are distinct from those of the desensitised state structure and are compatible with experimental structures of Cys-loop receptors captured in a closed/resting state. CONCLUSIONS AND IMPLICATIONS: Our model suggests that the side chains of α4 L257 (9') and α4 L264 (16') are the main constrictions in the transmembrane pore. The involvement of position 9' in channel gating is well established, but position 16' was only previously identified as a gate for the bacterial channels, ELIC and GLIC. L257 but not L264 was found to influence the slow component of desensitisation. The structure of the antagonist-bound state proposed here should be valuable for the development of therapeutic or insecticide compounds.
© 2019 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31062355      PMCID: PMC6609542          DOI: 10.1111/bph.14698

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  43 in total

1.  Crystal structure of an ACh-binding protein reveals the ligand-binding domain of nicotinic receptors.

Authors:  K Brejc; W J van Dijk; R V Klaassen; M Schuurmans; J van Der Oost; A B Smit; T K Sixma
Journal:  Nature       Date:  2001-05-17       Impact factor: 49.962

2.  Development and testing of a general amber force field.

Authors:  Junmei Wang; Romain M Wolf; James W Caldwell; Peter A Kollman; David A Case
Journal:  J Comput Chem       Date:  2004-07-15       Impact factor: 3.376

3.  Refined structure of the nicotinic acetylcholine receptor at 4A resolution.

Authors:  Nigel Unwin
Journal:  J Mol Biol       Date:  2005-01-25       Impact factor: 5.469

4.  The Amber biomolecular simulation programs.

Authors:  David A Case; Thomas E Cheatham; Tom Darden; Holger Gohlke; Ray Luo; Kenneth M Merz; Alexey Onufriev; Carlos Simmerling; Bing Wang; Robert J Woods
Journal:  J Comput Chem       Date:  2005-12       Impact factor: 3.376

Review 5.  Desensitization of neuronal nicotinic receptors.

Authors:  Michael W Quick; Robin A J Lester
Journal:  J Neurobiol       Date:  2002-12

6.  Mutations in the channel domain alter desensitization of a neuronal nicotinic receptor.

Authors:  F Revah; D Bertrand; J L Galzi; A Devillers-Thiéry; C Mulle; N Hussy; S Bertrand; M Ballivet; J P Changeux
Journal:  Nature       Date:  1991-10-31       Impact factor: 49.962

7.  Coupling of agonist binding to channel gating in an ACh-binding protein linked to an ion channel.

Authors:  Cecilia Bouzat; Fernanda Gumilar; Guillermo Spitzmaul; Hai-Long Wang; Diego Rayes; Scott B Hansen; Palmer Taylor; Steven M Sine
Journal:  Nature       Date:  2004-08-19       Impact factor: 49.962

8.  Internal hydration increases during activation of the G-protein-coupled receptor rhodopsin.

Authors:  Alan Grossfield; Michael C Pitman; Scott E Feller; Olivier Soubias; Klaus Gawrisch
Journal:  J Mol Biol       Date:  2008-05-22       Impact factor: 5.469

9.  Unconventional pharmacology of a neuronal nicotinic receptor mutated in the channel domain.

Authors:  D Bertrand; A Devillers-Thiéry; F Revah; J L Galzi; N Hussy; C Mulle; S Bertrand; M Ballivet; J P Changeux
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

10.  Mechanics of channel gating of the nicotinic acetylcholine receptor.

Authors:  Xinli Liu; Yechun Xu; Honglin Li; Xicheng Wang; Hualiang Jiang; Francisco J Barrantes
Journal:  PLoS Comput Biol       Date:  2008-01       Impact factor: 4.475

View more
  4 in total

1.  A Computational Analysis of the Factors Governing the Dynamics of α7 nAChR and Its Homologs.

Authors:  Alican Gulsevin; Jens Meiler; Nicole A Horenstein
Journal:  Biophys J       Date:  2020-09-16       Impact factor: 4.033

2.  Structure and gating mechanism of the α7 nicotinic acetylcholine receptor.

Authors:  Colleen M Noviello; Anant Gharpure; Nuriya Mukhtasimova; Rico Cabuco; Leah Baxter; Dominika Borek; Steven M Sine; Ryan E Hibbs
Journal:  Cell       Date:  2021-03-17       Impact factor: 41.582

3.  Structural Insights into the Role of β3 nAChR Subunit in the Activation of Nicotinic Receptors.

Authors:  Petros Giastas; Athanasios Papakyriakou; George Tsafaras; Socrates J Tzartos; Marios Zouridakis
Journal:  Molecules       Date:  2022-07-20       Impact factor: 4.927

4.  Simulations of Promising Indolizidine-α6-β2 Nicotinic Acetylcholine Receptor Complexes.

Authors:  Francis A Acquah; Matthew Paramel; Adama Kuta; Syed R Hussaini; David R Wallace; Blaine H M Mooers
Journal:  Int J Mol Sci       Date:  2021-07-25       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.